Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

On the second floor of The Laurelton, a school-turned-office building in Irondequoit, Rochester Clinical Research, or RCR, ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design ...

For some people, the classic symptoms of a sinus infection, including nasal congestion and discharge, are also accompanied by ...

Children of women with epilepsy prescribed antiseizure medications do not have significant neurodevelopmental differences at age 6 years.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Immunovant anticipates initiating clinical trials evaluating IMVT-1402 in a total of ten indications by March 31, 2026. Neurology Program: ...

Mild electrical brain stimulation did not further improve motor recovery in stroke survivors, according to late-breaking science presented at the American Stroke Association's International Stroke ...